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Abstract 
Aim: Around one-third of patients with Crohns disease are affected by Crohns fistula-in-
ano (pCD). It typically follows a chronic course and patients undergo long-term medical and 
surgical therapy. We set out to describe current surgical practice in the management of pCD 
in the UK. 
 
Methods: A survey of surgical management of pCD was designed by an expert group of 
colorectal surgeons and gastroenterologists. This assessed acute, elective, multidisciplinary 
and definitive surgical management. A pilot of the questionnaire was undertaken at the 
Digestive Disease Federation 2015 meeting. The survey was refined and distributed 
nationally through the trainee collaborative networks.  
 
Results: National rollout obtained responses from 133 surgeons of 179 approached 
(response rate 74.3%). At first operation, 32% surgeons would always consider drainage of 
sepsis and 31.1% would place a draining seton. At first elective operation, 66.6% would 
routinely insert of draining seton, and 84.4% would avoid cutting seton. The IBD 
multidisciplinary team was available to 87.6% respondents, although only 25.1% routinely 
discussed pCD patients. Anti-TNF-ɲ therapy was routinely considered by 64.2%, although 
44.2% left medical management to gastroenterology. Common definitive procedures were 
removal of seton only (70.7%), fistulotomy (57.1%), advancement flap (38.9%), fistula plug 
(36.4%) and ligation of intersphincteric track (LIFT) procedure (31.8%). Indications for 
diverting stoma or proctectomy were intractable sepsis, incontinence, and poor quality of 
life. 
 
Discussion: This survey has demonstrated areas of common practice, but has also 
highlighted divergent practice including choices of definitive surgery and multimodal 
management. Practical guidelines are required to support colorectal surgeons in the UK. 
 
What does this paper add to the literature?  
This study describes variation in surgical management of fistulating perianal Crohns disease 
across the UK, and is a first step towards establishing UK practice guidelines. 
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Introduction 
Perianal disease affects an estimated 34% of patients with Crohns disease, with a Crohns 
fistula-in-ano occurring in around 60% of patients. [1,2]. Perianal fistulating disease  (pCD) 
represents a significant challenge for patients, physicians and surgeons. Despite advances in 
treatment, long-term remission will only be achieved for two thirds of patients with simple 
fistulae and just a third of patients with complex fistulae [3]. 
 
Due to the paucity of large scale, well-designed, controlled trials, the majority of guidelines 
for managing perianal fistulating disease are based on consensus of expert opinion. Much of 
the published literature focuses on medical management, leaving gaps in guidance for 
surgeons [4,5]. 
 
A multidisciplinary approach appears to improve quality of care for patients with CD[9], 
however, the medical and surgical approach to its management may differ. The recent 
Delphi exercise by the Bowel Disease Research Foundation and the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI) has identified the management of 
fistulating pCD as an area requiring further research[10]. Using the established surgical 
research collaboratives[11] we sought to identify variations in current surgical management 
of this debilitating condition. 
 
The aim of this study was to report current colorectal practice in the surgical management 
of fistulating perianal Crohns disease in the United Kingdom (UK). 
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Method 
The survey was devised by a group of surgeons and gastroenterologists with an interest in 
inflammatory bowel disease (IBD), and further assessed and altered by patient consultation. 
The questionnaire was designed to audit practice in four areas: assessment and 
management of acute presentation, assessment and management of elective presentation, 
multidisciplinary management and definitive surgical management.  Questionnaires were 
anonymous at respondent level. 
 
The questions asked are included in the data tables 1-5 included in the results section.    
Responses were designed to be either binary (Yes/No), describe frequency using a four 
point scale (always, sometimes, occasionally, never), or selection of options from a menu. 
Where options were provided, instructions of select one or select as many as apply were 
clear, with an other option provided. 
 
A pilot of the survey was undertaken at the Digestive Disorders Federation (London July 
2015), with instructions to complete the survey and to offer critique of questions where 
appropriate. Following critique of the questionnaire, minor clarifications were made to 
wording of two questions, the option set was changed for two questions to widen range of 
timing options, and one additional option was included in a question on treatment. 
 
The full questionnaire was run through the UK surgical trainee research collaboratives, led 
jointly by the South Yorkshire Surgical Research Group (SYSuRG) and the North-West 
Research Collaborative (NWRC). Collaborators were asked to deliver the questionnaire to 
consultant colorectal surgeons in their units. Initial contact was made via the National 
Research Collaborative email lists and electronic contact made to local collaborative leads 
and cascaded locally. Collaborators were asked to support delivery of hard-copy 
questionnaires locally to Consultants and return at least three completed questionnaires to 
the Research Electronic Data Capture (REDCap) system, hosted by the University of 
Sheffield [12]. Although questionnaires were anonymous at respondent level, the number of 
centres and participants included was recorded by collaborators. 
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Numerical data from the questionnaire was collated and presented in a descriptive manner 
only. Where binary answers were changed to four point answers for the final study, yes and 
no options were analysed as always and never responses respectively. Free text data on 
indications for stoma and proctectomy were collated and representative statements 
reported.  
 
Ethical approval was not required for service evaluation of current practice. 
 
Results 
In the pilot phase, 35 questionnaires were distributed and 21 were returned (response rate 
60%). In the full review phase, 133 responses were received from a potential population of 
179 Consultant colorectal surgeons in participating centres (74.3% response rate). Of these, 
70 practised in district general hospitals and 63 in teaching hospitals, accounting for 32 
different centres across the UK, including centres in Wales and Scotland. For final analysis, 
both phases were pooled, giving a total of 154 responses of 214 (71.9% of all distributed 
questionnaires).  
 
Acute management of perianal sepsis 
This section addressed patients admitted acutely with perianal symptoms. There was 
variation in the use of perioperative antibiotics in the acute setting, with 39.6% of 
respondents always using them and 5.8% never using them. Most respondents (42.2%) 
would start antibiotic therapy pre-operatively on the ward or in clinic, with 40.9% starting 
therapy at induction of anaesthesia. The antibiotic of choice was metronidazole (77.9%), 
followed by co-amoxiclav (35.1%) and ciprofloxacin (20.1%). Few respondents would always 
ask for pre-operative imaging in the acute setting (7.1%), but the majority would seek 
imaging frequently (37.0%) or occasionally (51.9%). Where imaging was used, magnetic 
resonance imaging (MRI) of the pelvis was the preferred modality (96.1%), with a small 
minority using endo-anal ultrasound (2.5%) or CT (1.9%). 
 
Where the diagnosis of Crohns disease was suspected but not yet established, respondents 
were asked to report which investigations they would use to confirm or refute this. Faecal 
calprotectin was routinely used by 22.9%, colonoscopy always used by 57.1%, flexible 
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sigmoidoscopy always used by 16.8% and MR small bowel by 9.7%. Conversely, 25% of 
respondents would never use faecal calprotectin to aid diagnosis, 3.2% would not use 
colonoscopy, 18% would not use flexible sigmoidoscopy, and 13.6% would not use MR of 
small bowel. No respondents routinely used video capsule endoscopy (VCE) to confirm 
diagnosis of Crohns disease, and 40.2% would never use VCE in this setting (Table 1). 
 
Crohns fistula in acute setting. 
We asked respondents to identify which procedures they would routinely consider in an 
operation for an acutely symptomatic/emergency presentation of pCD; 32% would drain 
sepsis, 31.1% would consider placement of a draining seton if appropriate, and 0.6% would 
consider excision of fistula track. The majority of respondents (89.6%) indicated that they 
would never consider a cutting seton in this setting (Table 2). 
 
Respondents reported on what advice they would give to a less experienced surgeon (a 
general surgical colleague or registrar) undertaking surgery in this setting. Responses tended 
to recommend a more conservative approach with 43.5% advocating drainage of sepsis 
19.5% advocating placement of a draining seton, and 94.8% advising against a cutting seton. 
Free text comments from two respondents indicated a feeling that only an experienced 
colorectal surgeon should be undertaking these procedures. 
 
Subsequent elective surgery 
The survey elicited procedure preferences for the first subsequent elective examination 
under anaesthetic (EUA). As in the acute setting, draining seton was routinely considered 
(66.6%) and cutting seton was avoided (84.4%). Where preferences were indicated, 
Ethibond ® (Ethicon) was the preferred seton material for 41.5%, silastic slings for 24.6% 
and comfort drains ® (Agency for Medical Innovation) in 3.2%. Other procedures such as 
excision of track, fistulotomy and faecal diversion were not considered options in this 
context by 62.9%, 35.7% and 33.1% of surgeons respectively.  
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If a fistula was found at EUA, 30.6% would routinely undertake post-operative MRI. If a 
fistula was not identified, but suspected, 63.9% would routinely undertake post-operative 
MRI. Routine repeat EUA would be performed by 16.5% of respondents, although 75.9% of 
respondents indicated that they would frequently or occasionally undertake repeated EUA, 
suggesting a selected case approach. Post-operative antibiotics were routinely used by 
11.2% of respondents, and in selected cases (frequently/occasionally) by 75.0% (Table 3). 
 
Medical and multi-modal management of pCD 
An inflammatory bowel disease MDT was available to 87.6% of respondents. Of these, 
25.1% routinely discussed all cases of pCD in this setting and only 0.7% of respondents 
never discussed patients. A multi-modal approach utilising joint medical and surgical 
therapy was routinely used by 28.6% of respondents, with just 1.9% not using a combined 
approach (Table 4).  
 
Gastroenterology follow-up was arranged for all patients by 71.4% of respondents. 
Immunosuppressant therapy was routinely used in treatment of this condition by 32.8% of 
respondents, with 58.8% indicating a selected-case approach. Eight responses were 
excluded from this analysis as their response from the pilot survey could not be mapped to 
the final questionnaire. 
 
Surgeons were asked to identify which drug(s) they would prefer a patient to receive as part 
of multi-modal care. Anti-TNF-ɲ therapy was most frequently preferred (64.2%), followed by 
azathioprine (33.7%). Despite expressing preferences, the final decision on medical 
management was left with a gastroenterologist by 42.2% of surgeons. Summary of results is 
presented in Table 4. 
 
The decision on seton removal was made by surgeons in 64.2% of cases, the 
multidisciplinary team in 33.7% of cases and by gastroenterologists in 5.8% of cases. The 
patient made the decision for seton removal in 4.5% of responses. A free-text option was 
available to report timing of seton removal. Responses indicated that this was highly 
variable and tailored to the patient. In some cases, timings were related to surgery e.g. 3 
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months post-op, and in others related to biologic therapy e.g. after third dose. Respondents 
also indicated that it might be left in-situ indefinitely. 
 
Definitive Surgical Management of pCD 
Eleven surgical procedures were considered as options by respondents as options to 
facilitate definitive closure of a fistula. The most frequently considered options were 
removal of seton only (70.7%), fistulotomy (57.1%), advancement flap (38.9%), fistula plug 
(36.4%) and ligation of intersphincteric track (LIFT) procedure (31.8%). Fistulectomy (27.9%), 
fibrin glue (12.9%) and local perineal flaps (7.8%) were used by fewer respondents. Early 
adopters of technology indicated use of over the scope clip (OTSC) (1.2%), video assisted 
fistula closure (VAAFT) (1.9%) and fistula-assisted laser closure (FiLaC) (0.6%). 
 
Most respondents used diverting stoma and proctectomy on a selected case basis, with only 
12.3% of respondents never using a stoma and 12.9% never considering proctectomy. Free-
text responses defining indications for these were similar with the phrase failed bottom 
used by many respondents. This was defined as recurrent or chronic perianal sepsis, 
incontinence, and symptoms or proctitis refractory to medical therapy. Dysplasia and 
malignancy were reported as specific indications for proctectomy. Patient choice was 
identified by several respondents as a factor in their decision to undertake these 
procedures. Where proctectomy was performed, a small perineal defect would be primarily 
closed, but respondents preferred flap-based perineal reconstruction if a large defect 
remained. 
 
A significant minority (41.5%) of respondents indicated that they would treat rectovaginal 
fistula. This group of respondents would use definitive procedures including advancement 
flap (21.5%), fistula plug (10.9%), Martius flap (9.3%), omental interposition (6.2%) and LIFT 
procedure (4.6%) to treat recto-vaginal fistula. A diverting stoma would be used by 6.2% of 
respondents. A summary of definitive options used in perianal and rectovaginal fistulae are 
presented in Table 5. 
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Discussion  
This study has used a collaborative approach to assess current UK surgical practice in 
fistulating perianal Crohns disease. It has identified areas of common practice, including 
choice of imaging modality, antibiotics and avoidance of sphincter-disrupting treatments 
such as a cutting seton. The survey has clearly exposed variation in practice in the 
management of fistulating perianal Crohns disease.   
 
There are limitations associated with survey-based research including responder bias. We 
attempted to address these in the study design by using personal contacts and trainee-
consultant relationships with the opportunity for case-based discussions over impersonal 
electronic surveys with attendant poor response rates. Mitigation against survey fatigue due 
to length of questionnaire was also evident in engagement of local collaborators to deliver 
and complete the questionnaire. Anonymous participation in the survey may also have 
helped improve response rates, as there was no concern about identification or challenge 
related to practice. The high response rate was achieved with the support of the trainee 
collaborative networks. 
 
Management of a condition with variable presentations and degrees of severity such as 
fistulating perianal Crohns disease, will inevitably lead to some difficulties in achieving clear 
agreement around routine practice as management is rightly tailored to each case. This is 
reflected by the high proportion of respondents who selected frequently or occasionally 
as options.  
 
There is little evidence on the use of antibiotics alone in the treatment of perianal Crohns 
disease, with meta-analyses on the use of ciprofloxacin suggesting a marginal effect in 
remission of Crohns fistula [13,14]. In combination with Adalimumab, it may offer 
additional benefit in healing [15]. Recent American guidelines suggest that antibiotics in 
perianal sepsis might be of benefit only in the immunosuppressed, or where there is 
systemic upset or cellulitis [16]. 
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Magnetic resonance imaging is well established as the imaging modality of choice in 
perianal Crohns disease, and has been used to guide therapy in one study [17].  Endo-anal 
ultrasound is not yet a widely used technology. It has a niche role here as a diagnostic 
adjunct in specialist hands [18],but has limitations depending on the type of fistula present 
[19].   
 
Surgeons used a variety of investigations for establishing the diagnosis of Crohns disease. 
Faecal calprotectin is a sensitive marker of mucosal inflammation, so may be raised in a 
number of non-Crohns related scenarios [20,21].  Endoscopic assessment allows visual and 
histologic assessment of the colon. The split between colonoscopy and flexible 
sigmoidoscopy may be associated with surgeons ruling out proctitis only rather than 
assessing the whole colon, as proctitis is a prognostic factor in mucosal healing [4] and also 
in persistence of fistula.  
 
The roles of anti-TNF-ɲ therapy and azathioprine are well established in this setting, so their 
positions as drugs of choice are merited [17,22,15]. Previous work has demonstrated that 
steroids should not be used for pCD alone, and their use in this setting runs counter to 
current guidelines [23,4].  The use of steroids to treat associated luminal disease may be 
appropriate, and it is possible that this factor was considered when responding to questions 
about best medical therapy [23]. 
 
In both acute and initial elective settings, the survey shows a tendency towards conservative 
and sphincter-preserving procedures, in the form of drainage of sepsis and use of draining 
seton. Respondents widely rejected the use of cutting setons in this group of patients. 
Patients with pCD tend to a chronic and recurrent disease course necessitating multiple 
interventions, and therefore efforts should be made to preserve continence where possible 
[24]. The conservative advice given to less experienced surgeons suggests UK practice is 
aimed at avoiding iatrogenic exacerbation of fistulating disease and tends to favour 
management by experienced colorectal surgeons. 
 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
The removal of seton timing varied with treatment intent, although in free text comments, 
respondents indicated that they tended to follow one of two published UK practices [17,25]. 
The perceived advantage of early removal of a seton is the removal of a splint maintaining 
patency of a fistula and allowing it to heal. The trade off is that removal too early in the 
treatment process might promote recurrent perianal sepsis. 
 
There is a wide range of procedures offered as definitive surgical options for patients with 
pCD. Draining seton alone, fistulotomy, fistula plug and LIFT have been described in the 
literature, with varying outcomes, although this is mostly observational and not trial based 
data[26,27,24]. The variety of choice in definitive surgery may reflect in part a lack of 
consensus and limited evidence for the surgical management of pCD, but may also be 
influenced by individual surgeon expertise. 
 
Much of the recent literature has focussed on a multimodal approach to pCD, with 
emphasis on sepsis control and institution of medical therapy (e.g. biologics) to aid fistula 
closure showing benefit over surgery alone [28,29]. Current trials are investigating various 
permutations of this approach [30]. It is encouraging that most respondents have access to 
an IBD MDT and utilise immunosuppressant drugs as part of their therapy, although only 
28% routinely employ this approach. This study did not explore make-up of the IBD MDT or 
whether it was supported at a local or regional level. 
 
This study reported that some  surgeons do not undertake proctectomy or stoma formation, 
or manage Crohns rectovaginal fistula. In light of the varied definitive options described, it 
is possible that a number of surgeons will simply place a seton and not offer any surgical 
options beyond that, perhaps preferring to refer on to specialist colleagues. Single centre 
experience with rectovaginal fistula, even in tertiary or quaternary centres comes from 
small cohorts [31,32]. As volume is associated with outcome in some aspects of colorectal 
surgery [33], perhaps centralisation of definitive surgery for pCD should be considered. This 
might offer better outcomes, but risks losing local expertise in peripheral hospitals [34]. 
Those who do undertake proctectomy or stoma formation broadly agreed on indications for 
these procedures. It is of note that patient preference or request was a recognised 
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indication, as quality of life in patients with pCD has been found to be improved in patients 
who have a stoma [35]. 
 
Conclusion 
This study reports on individual surgical approaches to pCD in the context of trends in 
national practice. Variation in practice will have implications for design of and 
implementation of future research interventions in pCD. Further work is required to reach 
consensus on standardisation of the pCD management pathway. In the interim, early and 
efficient control of sepsis, multimodal pCD management, and an emphasis on sphincter-
preserving surgical techniques are the current foundations of managing pCD in the UK. 
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 Response (%)  
In the acute setting: Always Frequently Occasionally Never Missing 
Would you use 
antibiotics? 
61 (39.6%) 45 (29.2%) 43 (27.9%) 2 (1.3%) 3 (1.9%) 
 Pre-
operatively 
Anaesthetic 
induction 
Post-operatively Other Missing 
When would you start 
them? 
65 (42.2%) 63 (40.9%) 10 (6.5%) 7 (4.5%) 9 (5.8%) 
List Ciprofloxacin Metronidazole Co-amoxiclav Gentamicin  
What antibiotics would 
you use? 
31 (20.1%) 121 (78.5%) 54 (35.1%) 22 (14.2%) - 
 Always Frequently Occasionally Never Missing 
Would you obtain pre-
operative imaging? 
11 (7.1%) 57 (37.0%) 80 (51.9%) 5 (3.2%) 1 (0.6%) 
If the diagnosis of 
Crohns disease was not 
established, would you 
use: 
Always Frequently Occasionally Never Missing 
Faecal Calprotectin 33 (21.4%) 36 (23.3%) 39 (25.3%) 36 (23.3%) 10 (6.5%)
Colonoscopy 88 (57.1%) 45 (29.2%) 16 (10.3%) 5 (3.2%) 0 
Flexible sigmoidoscopy 26 (16.8%) 37 (24.0%) 60 (38.9%) 28 (18.2%) 3 (1.9%) 
Video Capsule 
Endoscopy 
0 4 (2.6%) 83 (53.8%) 61 (38.6%) 6 (3.8%) 
MR Small Bowel 0 0 23 (14.9%) 
125 
(81.1%) 
6 (3.8%) 
Table 1: Summary of initial assessment and pre-operative management of perianal 
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 Response (%)  
If you were doing the case, 
would you consider: 
Always Frequently Occasionally Never Missing 
Incision and drainage of 
abscess 
50 (32.4%) 48 (31.1%) 44 (28.6%) 8 (5.1%) 4 (2.5%) 
Insertion of draining seton 48 (31.1%) 61 (43.5%) 35 (22.7%) 1 (0.6%) 10 (6.4%) 
Insertion of cutting seton 0 0 13 (8.4%) 138 (89.6%) 4 (2.5%) 
Excision of track 1 (0.6%) 0 45 (29.2%) 104 (67.5%) 4 (2.5%) 
  
If you were advising a 
colleague or registrar, 
would you advise: 
Always Frequently Occasionally Never Missing 
Incision and drainage of 
abscess 
67 (43.5%) 46 (29.8%) 31 (20.1%) 7 (4.5%) 3 (1.9%) 
Insertion of draining seton 30 (19.4%) 50 (32.4%) 60 (38.9%) 11 (7.1%) 3 (1.9%) 
Insertion of cutting seton 0 0 4 (2.5%) 146 (94.8%) 4 (2.5%) 
Excision of track 0 0 23 (14.9%) 125 (81.1%) 6 (3.8%) 
Table 2: Practice around surgery in the acute/urgent setting. 
 
 
 
 
Response (%)  
At first planned EUA, 
would you consider 
Always Frequently Occasionally Never Missing 
Insertion of draining seton 48 (31.1%) 61 (43.5%) 35 (22.7%) 1 (0.6%) 10 (6.4%) 
Insertion of cutting seton 0 0 13 (8.4%) 138 (89.6%) 4 (2.5%) 
Excision of track 1 (0.6%) 0 45 (29.2%) 104 (67.5%) 4 (2.5%) 
Fistulotomy 0 5 (3.2%) 88 (57.1%) 55 (35.7%) 6 (3.8%) 
Faecal diversion 0 0 54 (35.0%) 53 (34.4%) 47 (30.5%) 
  
After first elective 
procedure, would you 
routinely plan for: 
Always Frequently Occasionally Never Missing 
Post-operative antibioticś 15 (11.2%) 21 (15.7%) 79 (59.3%) 13 (9.7%) 5 (3.7%) 
Post-operative imaging if 
fistula found́ 48 (36.0%) 48 (36.0%) 32 (24.0%) 1 (0.7%) 4 (3.0%) 
Post-operative imaging if 
no-fistula found́ 85 (63.9%) 33 (24.8%) 9 (6.7%) 2 (1.5%) 4 (3.0%) 
Repeat EUA ́ 22 (16.5%) 47 (35.3%) 54 (40.6%) 6 (4.5%) 4 (3.0%) 
Table 3: Summary of management around first planned examination under anaesthetic. 
́Percentage based on 133 respondents from full survey as no equivalent response options 
used in pilot. 
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 Yes No Missing 
Do you have access 
to an IBD MDT? 
135 (87.6%) 14 (9.1%) 5 (3.2%) 
  Always Frequently Occasionally Never Missing 
Do you routinely 
discuss pCD patients 
in an IBD MDT?́ 
39 (25.1%) 58 (41.7%) 45 (32.3%) 1 (0.7%) 0 
Do you arrange 
follow up for 
patients with 
gastroenterology? 
110 (71.4%) 31 (22.3%) 9 (6.4%) 0 4 (2.6%) 
Do you use 
multimodal 
approach? 
44 (28.5%) 70 (45.5%) 19 (12.3%) 3 (1.9%) 18 (11.6%) 
Do you use 
immunosuppressant 
drugs?  
48 (32.8%) 58 (39.7%) 28 (19.1%) 8 (5.4%) 4 (2.7%) 
    
What drugs would you ask for to complement 
surgical therapy? 
n % 
 Glucocorticoid 
steroids 
34 22.0 
 Aminosalicylates 24 15.5 
 Azathioprine 52 33.7 
 6-Mercaptopurine 16 10.3 
 Methotrexate 23 14.9 
 Anti-TNF-ɲ therapy 99 64.2 
 Gastroenterology 
decide 
65 42.2 
Table 4: Summary responses and multimodal management approaches used. 
*Selected cases group was split into Frequently and Occasionally after pilot. ́Percentage 
based on 143 respondents who replied Yes to IBD MDT or missing responses (i.e. excludes 
those with no MDT). ́́ 8 patients excluded as option selected cases removed in full 
version. 
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Procedure Perianal Fistula (n=154) Rectovaginal fistula 
(n=64) 
Removal of Seton only 109 (70.7%) - 
Fistulotomy 88 (57.1%) - 
Fistulectomy 43 (27.9%) - 
Fistula Plug 56 (36.4%) 7 (10.9%) 
Advancement flap 60 (38.9%) 14 (21.5%) 
Fibrin Glue 20 (12.9%) - 
LIFT 46 (29.8%) 3 (4.6%) 
OTSC 2 (1.2%) - 
VAAFT 3 (1.9%) - 
FiLaC 1 (0.6%) - 
Local (Perineal) Flap 12 (7.8%) - 
Martius Flap - 6 (9.3%) 
Omental interposition - 4 (6.2%) 
Diverting stoma - 4 (6.2%) 
Table 5: Definitive surgical procedures and their use in perianal and rectovaginal fistula. 
 
